Overview of the Advantages and Disadvantages of Different Mucosal Sites for the Delivery of Nanoparticles
Attributed to:
MICA VACCINE FAPESP MICA: Pulmonary Delivery of a Targeted Mucosal Nanocarrier Vaccine for Pneumonia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/978-3-030-35910-2_3
Publication URI: http://dx.doi.org/10.1007/978-3-030-35910-2_3
Type: Book Chapter
Book Title: Mucosal Delivery of Drugs and Biologics in Nanoparticles (2020)
Page Reference: 61-82
ISSN: 1614-2942